Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Magnisense logo — Creating rapid diagnostic solutions for cardiovascular illne...

Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments

Founded 2003 1 employees Series Unknown Total: $11.70M Health Care

General Information

Company Name Magnisense
Founded Year 2003
Founders / Decision Makers
Team member
Employees 1
Industries Health Care
Funding Stage Series Unknown
Social

Get notified when Magnisense moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Magnisense

Magnisense is a health care startup that has been making waves in the industry since its founding in 2003. The company's slogan "Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments" embodies its core mission. In its most recent funding round in October 2018, Magnisense secured a notable €5.00M Venture Round investment. This funding came from a consortium of investors including Noshaq, Provestis SAS, Concorde Capital, Victor Douce, and Minv. The company's innovative approach to emergency diagnostic tests for cardiovascular diseases, leveraging its proprietary MIAtek® technology, has captured the attention and investment of these prominent players in the industry.

Taxonomy: cardiovascular diagnostics, emergency diagnostics, MIAtek® technology, proprietary diagnostic instruments, rapid diagnostics, diagnostic tests, cardiovascular diseases, innovation, healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 5
Investor Investor Investor
•••• •••• 		26 Oct 2018
Venture Round •••••• 2
Investor Investor
27 Nov 2015
Grant •••••• 1
Investor
02 Feb 2015

Magnisense Alternatives & Competitors

Magnisense vs
Lincoln Diagnostics , LLC
Lincoln Diagnostics , LLC United States

Determined to deliver high-standard diagnostic services.

41 employees
Health Care, Health and Wellness
Magnisense vs
Zet Biotech
Zet Biotech

Biotech company providing innovative diagnostic molecular tests and rapid diagnostic test kits.

Magnisense vs
Accriva Diagnostics
Accriva Diagnostics

Empowering healthcare with innovative near-patient testing and diagnostic solutions since 2009.

Series Unknown
1001-5000 employees
Health Care, Medical Devices

FAQ About Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments
Magnisense was founded in 2003.
Magnisense operates in the following industries: Health Care.
Magnisense has approximately 1 employees.
Magnisense has completed 3 funding rounds, raising a total of $11.70M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Magnisense include Lincoln Diagnostics , LLC, Zet Biotech, Accriva Diagnostics, Eclipse Diagnostics, Webb Diagnostic Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Magnisense and Lincoln Diagnostics , LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Magnisense and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy